Previous 10 | Next 10 |
2023-09-24 13:01:04 ET The growing popularity of GLP-1 weight-loss drugs may be already impacting demand for certain procedures like body contouring and dermo fillers, according to Needham’s Q3 aesthetics procedures survey. Needham asked respondents who were familiar with GLP-1 d...
2023-09-22 07:01:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s a well-known fact that the “big money” on Wall Street wants to draw retail investors’ focus away from great stock deals. This is simply because if everyday inve...
2023-09-04 09:00:00 ET Summary InMode investors experienced significant volatility as INMD was hammered after its pre-earnings surge. As a result, it nearly gave up all its July gains. Investors are likely still concerned about the impact of high interest rates on medical capital ...
2023-08-24 10:30:54 ET Summary INMD's P/E and EV/EBITDA ratios have fallen sharply in the past 2-3 years despite its revenues and net income more than doubling in this period. The prospect of continued profitable growth and a history of beating analysts' estimates suggest that thi...
2023-08-18 06:20:21 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Forever stocks can be tough picks in today’s market. The stock market goes through many twists and turns. Sharp price movements can rattle many investors, but many savvy investors pr...
2023-08-11 08:35:00 ET InMode (NASDAQ: INMD) is a great stock to consider if you're looking to make an investment of around $5,000. Thanks to its innovative, less-invasive devices for performing medical-aesthetics treatments, it has the opportunity to steal market share from traditi...
2023-08-09 10:12:00 ET A lot of (digital) ink tends to get spilled about how much businesses grow their revenues each quarter. But sometimes, like with InMode 's (NASDAQ: INMD) second-quarter earnings, the most exciting figure isn't the top-line sales. Instead, there's a certain...
2023-07-29 09:45:00 ET Buying more shares of one of your winning investments can feel good. Aside from confirming your commitment to a smart decision from before, you also ideally get the enjoyment of seeing the stock's next leg of growth. On that note, I've been a shareholder of the me...
2023-07-27 17:00:23 ET Image source: The Motley Fool. InMode (NASDAQ: INMD) Q2 2023 Earnings Call Jul 27, 2023 , 8:30 a.m. ET Operator Continue reading For further details see: InMode (INMD) Q2 2023 Earnings Call Transcript
2023-07-27 11:13:07 ET InMode Ltd. (INMD) Q2 2023 Earnings Conference Call July 27, 2023, 08:30 AM ET Company Participants Miri Segal - Investor Relations, MS-IR LLC Moshe Mizrahy - Chairman and CEO Shakil Lakhani - President, North America Yair Malca - Chief...
News, Short Squeeze, Breakout and More Instantly...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...